This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Université Libre De Bruxelles. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Panagiota Sotiropoulou: Innovator in Cancer Research
Introduction
Panagiota Sotiropoulou is a prominent inventor based in Kraainem, Belgium. She has made significant contributions to the field of cancer research, particularly in the detection and quantification of circulating tumor cells.
Latest Patents
Sotiropoulou holds a patent titled "Detection, quantification and/or isolation of circulating tumor cells based on the expression of CD321 marker." This application discloses CD321 as a useful global marker of circulating tumor cells (CTCs) and provides related methods and kits relying on the detection of CD321. She has 1 patent to her name.
Career Highlights
Panagiota Sotiropoulou is affiliated with the Université Libre de Bruxelles, where she conducts her research. Her work focuses on innovative methods to improve cancer diagnostics and treatment.
Collaborations
Sotiropoulou collaborates with notable researchers in her field, including Cédric Blanpain and Ievgenia Pastushenko. Their combined expertise enhances the impact of their research on cancer detection and treatment.
Conclusion
Panagiota Sotiropoulou is a key figure in cancer research, with her innovative work paving the way for advancements in the detection of circulating tumor cells. Her contributions are vital for improving cancer diagnostics and patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile